RENBRENOVARO BIOSCIENCES INC.

Nasdaq enochianbio.com


$ 0.91 $ -0.04 (-3.94 %)    

Thursday, 16-May-2024 15:35:53 EDT
QQQ $ 452.16 $ -1.32 (-0.29 %)
DIA $ 399.52 $ -0.11 (-0.03 %)
SPY $ 528.96 $ -0.97 (-0.18 %)
TLT $ 92.00 $ -0.10 (-0.11 %)
GLD $ 220.14 $ 0.15 (0.07 %)
$ 0.9473
$ 1.12
$ 0.91 x 100
$ 0.00 x 0
$ 0.82 - $ 1.15
$ 0.39 - $ 5.25
237,061
na
101.82M
$ 0.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 10-02-2023 06-30-2023 10-K
5 05-12-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-Q
7 03-07-2023 09-30-2022 10-Q
8 02-27-2023 06-30-2022 10-K
9 05-12-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 09-24-2021 06-30-2021 10-K
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 11-12-2020 09-30-2020 10-Q
16 09-23-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-10-2020 12-31-2019 10-Q
19 11-13-2019 09-30-2019 10-Q
20 09-30-2019 06-30-2019 10-K
21 05-16-2019 03-31-2019 10-Q
22 02-13-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 10-01-2018 06-30-2018 10-K
25 05-15-2018 03-31-2018 10-Q
26 02-09-2018 12-31-2017 10-Q
27 11-20-2017 09-30-2017 10-Q
28 09-29-2017 06-30-2017 10-K
29 05-15-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-Q
31 11-14-2016 09-30-2016 10-Q
32 09-28-2016 06-30-2016 10-K
33 05-13-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-Q
35 11-13-2015 09-30-2015 10-Q
36 05-13-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 renovarocube-wholly-owned-subsidiary-of-renovaro-unveils-flamingo-a-multi-cancer-detection-model-contributing-to-its-mission-to-transform-early-cancer-diagnostics

RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innov...

 renovarocube-to-acquire-100-ownership-of-cyclomics-reinforcing-cutting-edge-cancer-diagnostics-partnership-financial-terms-not-disclosed

Renovaro Inc. (NASDAQ:RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in u...

 renovaro-announces-the-appointment-of-professor-dr-geert-kazemier-as-the-chairman-of-its-scientific-advisory-board

Renovaro Inc. (NASDAQ:RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the...

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 hit-with-short-seller-report-renovaro-biosciences-comments-on-hindenburgs-opinion-piece

Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board....

 renovaro-biosciences-responds-to-hindenburgs-recent-opinion-piece-says-the-board-and-management-remain-confident-in-the-future-of-the-company-and-believe-people-will-see-these-baseless-attacks-for-what-they-are

The following is a statement by Renovaro (NASDAQ:RENB) in response to Hindenburg's recent opinion piece:We felt compelled t...

 why-ipg-photonics-shares-are-trading-lower-by-around-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed four...

 renovaro-biosciences-faces-turmoil-after-hindenburg-report-accusing-questionable-merger-and-governance-stock-crashes

Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violati...

 watching-renovaro-biosciences-hindenburg-research-issues-report-titled-renovaro-biosciences-a-worthless-ai-shell-game-with-a-murderous-magician-past

https://hindenburgresearch.com/renovaro/  

 why-adial-pharmaceuticals-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.

 top-5-health-care-stocks-that-may-plunge-in-october

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

 renovaro-biosciences-and-ai-health-company-gedi-cube-sign-definitive-agreement-to-combine-gedi-cube-to-become-a-wholly-owned-subsidiary-of-renovaro-in-stock-for-stock-acquisition-gedi-cube-holders-to-own-50-of-combined-company

The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION